Prevalence and Risk Factors Associated with Epilepsy in Six Health Districts of Mali: A Community-Based Cross-Sectional and Nested Case-Control Study.


Journal

Neuroepidemiology
ISSN: 1423-0208
Titre abrégé: Neuroepidemiology
Pays: Switzerland
ID NLM: 8218700

Informations de publication

Date de publication:
2022
Historique:
received: 15 08 2021
accepted: 10 01 2022
pubmed: 20 1 2022
medline: 22 4 2022
entrez: 19 1 2022
Statut: ppublish

Résumé

In resource-limited countries, epilepsy prevalence is underestimated and little is known about its risk factors. This study aimed to determine the prevalence and risk factors for epilepsy in six health districts (HDs) in Mali. A community-based cross-sectional and nested case-control study was conducted in 180 villages with the highest number of suspicious epilepsy cases (SECs) in the six study HDs. The SECs were observed as part of a Phase 1 screening conducted by community health workers. For the nested case-control study, one case was matched with at least one control based on residence and age. A case of epilepsy was a person diagnosed with convulsive epilepsy after clinical assessment by a neurologist. A control was a person diagnosed as normal after neurological assessment by a neurologist. Data were collected on sociodemographic characteristics, familial and medical history of epilepsy, consanguinity, place of delivery, preterm birth, length/type of delivery, and history of meningitis and cerebral malaria. A univariate and multivariate binomial logistic regression model was used to analyse factors associated with epilepsy. A total of 1,506 cases of epilepsy and 2,199 controls were enrolled in six HDs. The mean prevalence of epilepsy was 2‰, with the highest in Kenieba (3‰), a previously meso-endemic-onchocerciasis HD, and the lowest in Kadiolo (1.5‰), a hypo-endemic-onchocerciasis HD. Age (adjusted odds ratio [aOR] = 1.02 [95% confidence intervals [CI] 1.02-1.03]), history of cerebral malaria (aOR = 11.41 [95% CI 8.86-14.85]), history of meningitis (aOR = 1.95 [95% CI 1.16-3.29]), living in the HD of Tominian (aOR = 1.69 [95% CI 1.29-2.22]), delayed delivery (aOR = 3.21 [95% CI 2.07-5.07]), and dystocia (aOR = 3.37 [95% CI 2.03-5.73]) were all significantly associated with epilepsy. The prevalence of epilepsy (3‰) in a previously meso-endemic-onchocerciasis HD was much lower than the prevalence (13.35‰) documented in onchocerciasis endemic areas in 2,000. This decrease epilepsy prevalence in the previously meso-endemic region was induced by onchocerciasis, and the reduction was due to an effective community direct treatment with ivermectin programme. Cerebral malaria and obstetrical complications were the main risk factors for epilepsy and interventions improving malaria prevention/treatment and optimizing prenatal and obstetrical care need to be implemented to reduce incidence.

Identifiants

pubmed: 35045422
pii: 000522021
doi: 10.1159/000522021
doi:

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-137

Subventions

Organisme : FIC NIH HHS
ID : D43 TW008652
Pays : United States

Informations de copyright

© 2022 S. Karger AG, Basel.

Auteurs

Housseini Dolo (H)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Département d'Enseignement et de Recherche en Santé Publique et Spécialités, FMOS, USTTB, Bamako, Mali.
Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Fatoumata Dite Nènè Konipo (FDN)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Fanta Sow (F)

Département d'Enseignement et de Recherche en Santé Publique et Spécialités, FMOS, USTTB, Bamako, Mali.

Fousseyni Kane (F)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.

Modibo Sangare (M)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.

Mariam Daou (M)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Moussa Sangare (M)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Département d'Enseignement et de Recherche en Santé Publique et Spécialités, FMOS, USTTB, Bamako, Mali.
Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Oumar Sangho (O)

Département d'Enseignement et de Recherche des Sciences Biologiques et Médicales (DERSBM), Faculté de Pharmacie (FAPH), USTTB, Bamako, Mali.

Harouna Koné (H)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Fousseyni D Coulibaly (FD)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Siaka Yamoussa Coulibaly (SY)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Salif Seriba Doumbia (SS)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Abdou Koita (A)

Département de Neurologie, Centre Hospitalo Universitaire, Gabriel Toure, Bamako, Mali.

Birama Sangaré (B)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Samba Djimdé (S)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Sekouba Goita (S)

Département de Neurologie, Centre Hospitalo Universitaire, Gabriel Toure, Bamako, Mali.

Tenimba Bagayoko (T)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Aly Badhara Dem (AB)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Zoumana Fomba (Z)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Mamadou Gari (M)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Chimène Essi Kotchene (CE)

Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Kissy Elvira Orsot (KE)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Dansine Diarra (D)

Faculté d'Histoire et de Geography, Université des Sciences Sociales et de Gestion de Bamako (USSGB) Bamako, Bamako, Mali.

Robert Colebunders (R)

Global Health Institute, University of Antwerp, Antwerpen, Belgium.

Yaya Ibrahim Coulibaly (YI)

Unité Filariose, International Center of Excellence in Research, USTTB, Bamako, Mali.

Hamadoun Sangho (H)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Département d'Enseignement et de Recherche en Santé Publique et Spécialités, FMOS, USTTB, Bamako, Mali.

Youssoufa M Maiga (YM)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Département de Neurologie, Centre Hospitalo Universitaire, Point G, Bamako, Mali.

Seydou Doumbia (S)

Faculté de Medecine et d'Odonto Stomatologie (FMOS), Université Des Sciences, Des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Département d'Enseignement et de Recherche en Santé Publique et Spécialités, FMOS, USTTB, Bamako, Mali.
University Clinical Research Center (UCRC), University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH